GlassScriptPhysician profile
Alexander Tsinberg
NPI 1871545558
$6,239.42
in general payments reported to CMS, 2019-2025
46 companies · $812 in 2025
The $812 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $569 · 2021: $1,024 · 2022: $961 · 2023: $795 · 2024: $979 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,586.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $850.88 | 2020-2025 | Belbuca, Xtampza |
| Nevro Corp. | $580.70 | 2019-2024 | Senza |
| Abbott Laboratories | $443.35 | 2019-2025 | Proclaim |
| Abbvie INC. | $442.37 | 2021-2025 | Botox, Ubrelvy |
| Scilex Pharmaceuticals INC. | $348.97 | 2019-2023 | Ztlido |
| Nalu Medical, INC. | $335.44 | 2021-2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $291.07 | 2019-2021 | |
| Medtronic, INC. | $285.90 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Globus Medical, INC. | $282.55 | 2025 | Senza, Vyrsa V1 |
| Vertos Medical, INC. | $234.59 | 2021-2024 | Mild Device Kit |
| Averitas Pharma INC. | $233.94 | 2023-2025 | Qutenza |
| Novartis Pharmaceuticals Corporation | $171.47 | 2019-2021 | |
| Amgen INC. | $170.50 | 2019-2022 | |
| Stimwave Technologies Incorporated | $151.00 | 2019-2022 | |
| Medtronic USA, INC. | $122.25 | 2019-2020 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Tsinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.